The AIM-HI Accelerator Fund congratulates our six semi-finalists led by six aspiring women scientist-entrepreneurs. The winning early-stage oncology company of 2023 Women’s Venture Competition will receive up to $1 million in investment from AIM-HI and co-investors, subject to due diligence and negotiation. which will serve as early seed money for proof of concept and proof of value on the path to clinical trials and, eventually, to new effective therapeutics that could save patients’ lives.

Ready to do more? DONATE NOW and help us double the impact for women scientist-entrepreneurs who are creating life-saving oncology innovations!